Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

Tissue resident stem cells produce CCL5 under the influence of cancer cells and thereby promote breast cancer cell invasion.

Pinilla S., Alt E., Abdul Khalek FJ., Jotzu C., Muehlberg F., Beckmann C.

Laboratory Study, published in Cancer Lett (2009) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Cancer Lett (2009)
Country
Ireland
Reported sample size
—
Source database
PubMed
PMID
19427114
DOI
10.1016/j.canlet.2009.04.013
Citations
110

Abstract (original English)

In the present study, we investigated whether human adipose tissue derived stem cells (hASCs) could enhance tumor invasion and whether these hASCs could be a potential source of CCL5. We observed a significant increase in the number of breast cancer cells that invaded the matrigel when Co-cultured with hASCs. We found that hASCs produce CCL5 in the Co-culture and cancer cell invasion was diminished by an antibody against CCL5. Furthermore, cancer cell invasion in the Co-culture was associated with an elevated level of MMP-9 activity. We conclude that CCL5 plays a crucial role for tumor invasion in the interplay of tissue resident stem cells from the fat tissue and breast cancer cells.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Adipose TissueBreast NeoplasmsCell Line, TumorChemokine CCL5Coculture TechniquesCollagenDrug CombinationsHumansLamininMatrix Metalloproteinase 9

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.